| Financial Year |
March 31 2023 |
| Monetary Funds |
1,247,553,008.69 |
| Held-for-trading Financial Assets |
20,082,661.74 |
| Notes Receivable |
3,742,853.66 |
| Accounts Receivable |
2,217,034,841.11 |
| Advances to Suppliers |
379,636,323.71 |
| Other Receivables |
140,881,059.72 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
5,303,148.09 |
| Dividend Receivable |
-- |
| Inventories |
1,297,979,419.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
195,215,747.10 |
| Total Current Assets |
5,607,086,502.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
536,711,310.60 |
| Investment Properties |
3,020,778.94 |
| Fixed Assetes |
3,439,153,889.91 |
| Under-construction Projects |
269,938,018.15 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
377,822,662.14 |
| R&D expenses |
42,062,663.38 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
179,739,328.12 |
| Deferred Income Tax Assets |
195,266,810.31 |
| Other Non-Current Assets |
211,367,619.62 |
| Sub-Total of Non-Current Assets |
5,827,481,631.35 |
| Total Assets |
11,434,568,134.14 |
| Short-Term Loans |
1,002,193,310.95 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,001,746,089.14 |
| Accounts Payable |
1,342,304,171.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
85,450,989.54 |
| Taxes Payable |
35,296,438.00 |
| Interest Payable |
1,882,615.09 |
| Dividend Payable |
-- |
| Other payables |
305,077,829.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
128,862,939.58 |
| Other Current Liabilities |
15,531,004.83 |
| Sub-Total of Current Liabilities |
4,694,555,274.26 |
| Long-term Loans |
384,601,731.60 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,545,491.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
920,478,604.62 |
| Total Liabilities |
5,615,033,878.88 |
| Paid-In Capital(Or Share Stock) |
1,434,252,287.00 |
| Capital Surplus |
4,878,479,359.03 |
| Surplus Reserve |
260,716,048.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,181,257,653.15 |
| Minority Stockholder's Interest |
490,804,767.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,328,729,488.22 |
| Owner's Equity（Stockholder's Equity） |
5,819,534,255.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,434,568,134.14 |
